Xilio Therapeutics, Inc. (XLO): 4 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Mar 30, 2026 | Shannon James Samuel Director | 5,000 | $8.79 | $43.9K | no history |
| Jun 18, 2025 | Russo Rene Director, Officer | 36,289 | $0.68 | $24.7K | no history |
| Jun 18, 2025 | Shannon James Samuel Director | 70,000 | $0.69 | $48.3K | no history |
| Dec 19, 2024 | Gilead Sciences, Inc. TenPercentOwner | 1,759,978 | $1.04 | $1.8M | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.